Aytu BioPharma, Inc. (AYTU) vs Estrella Immunopharma, Inc. (ESLA)
A side-by-side comparison of Aytu BioPharma, Inc. and Estrella Immunopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AYTU
Aytu BioPharma, Inc.
$2.05HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
ESLA
Estrella Immunopharma, Inc.
$0.44HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AYTU vs ESLA
growth of $100 · dividends reinvested · last 5yAYTU -96.7% (-49.3%/yr)ESLA -95.5% (-46.2%/yr)ESLA compounded faster over this window
AYTU ESLA
AYTU vs ESLA: by the numbers
- •AYTU is the larger company ($22M vs $19M market cap).
- •Both run net losses; ESLA's is the smaller (0.00% vs -24.76% net margin).
Metrics side by side
Valuation
| Metric | AYTU | ESLA |
|---|---|---|
| P/S ratio | 0.38 | N/A |
| P/B ratio | 0.62 | N/A |
| FCF yield | 14.78% | N/A |
Profitability
| Metric | AYTU | ESLA |
|---|---|---|
| Gross margin | 63.95% | 0.00% |
| Operating margin | -14.44% | 0.00% |
| Net margin | -24.76% | 0.00% |
| ROE | -40.40% | N/A |
| ROIC | -14.21% | N/A |
Growth (annualized)
| Metric | AYTU | ESLA |
|---|---|---|
| Revenue CAGR (5Y) | -2.59% | N/A |
| Total return CAGR (5Y) | -48.14% | -46.34% |
Frequently asked
- How have AYTU and ESLA total returns compared?
- Over the past 5 years, AYTU delivered -48.14% and ESLA delivered -46.34% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Aytu BioPharma ROEEstrella Immunopharma ROEAytu BioPharma operating marginEstrella Immunopharma operating marginAytu BioPharma revenue growthEstrella Immunopharma revenue growthAytu BioPharma free cash flowEstrella Immunopharma free cash flow
Aytu BioPharma & Estrella Immunopharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.